On the mode of decrease of leukemic cells during treatment of acute leukemia

Eur J Cancer (1965). 1976 Feb;12(2):143-9. doi: 10.1016/0014-2964(76)90218-8.
No abstract available

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aminobiphenyl Compounds / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Asparaginase / therapeutic use
  • Bone Marrow / pathology
  • Cell Survival / drug effects
  • Child
  • Child, Preschool
  • Cytarabine / analogs & derivatives
  • Cytarabine / therapeutic use
  • Daunorubicin / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Humans
  • Leukemia / blood
  • Leukemia / drug therapy*
  • Leukemia / pathology
  • Leukocyte Count
  • Male
  • Mercaptopurine / therapeutic use
  • Mesylates / therapeutic use
  • Methotrexate / therapeutic use
  • Middle Aged
  • Neutrophils
  • Prednisolone / therapeutic use
  • Time Factors
  • Zinostatin / therapeutic use

Substances

  • Aminobiphenyl Compounds
  • Antineoplastic Agents
  • Mesylates
  • Cytarabine
  • Zinostatin
  • Prednisolone
  • Mercaptopurine
  • Asparaginase
  • Methotrexate
  • Daunorubicin